WHO recommends dolutegravir as preferred HIV treatment option in all populations
Source: who.int Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir […]
Source: who.int Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir […]